Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Donatella Baronciani, MD, Maddalena Casale, MD, Lucia De Franceschi, MD, Giovanna Graziadei, MD, Filomena Longo, MD, Raffaella Origa, MD, Valeria Maria Pinto, MD, Paolo Rigano, MD, Monia Marchetti, MD, Antonia Gigante, Emanuele Angelucci, MD, Maria Domenica Cappellini, MD, Achille Iolascon, MD PhD, Antonio Piga, Gian Luca Forni

Blood (2019) 134 (Supplement_1): 972.

https://doi.org/10.1182/blood-2019-128320

Published: 2019

Journal Articles

Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017

Donatella Baronciani, MD, Ariane Boumendil, PhD, Arnaud Dalissier, PhD, Javid Gaziev, Ardeshir Ghavamzadeh, MD, Josu de la Fuente, FRCP, PhD FRCPath, Marco Zecca, MD, Amal Al-Seraihy, MD, O. Alphan Kupesiz, MD, Abdelghani Tbakhi, MD, Gerard Socie, MD PhD, Vassiliki Kitra-Roussou, MD, Arjan Lankester, MD PhD, Gian Luca Forni, MD, Peter Bader, MD PhD, Emanuele Angelucci, MD

Blood (2018) 132 (Supplement 1): 168.

https://doi.org/10.1182/blood-2018-168

Published: 2018

Journal Articles

Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study

Donatella Baronciani, MD, Cristina Depau, MD, Clara Targhetta, MD, Sara Veronica Usai, MD, Anna Angela Di Tucci, MD, Claudio Romani, MD, Igor Tandurella, PhD, Emanuele Angelucci, MD

Blood (2014) 124 (21): 5905.

https://doi.org/10.1182/blood.V124.21.5905.5905

Published: 2014

Journal Articles

Once Daily Intravenous Busulphan Plus Fludarabine As New Reduced Toxicity Myeloablative Conditioning for Acute Myeloid Leukemia and MDS Allogeneic Transplantation

Donatella Baronciani, MD, Cristina Depau, MD, Clara Targhetta, MD, Anna Angela Di Tucci, MD, Daniele Derudas, MD, Fabio Culurgioni, PhD, Donatella Pulisci, PhD, Igor Tandurella, PhD, Emanuele Angelucci, MD

Blood (2014) 124 (21): 5861.

https://doi.org/10.1182/blood.V124.21.5861.5861

Published: 2014

Journal Articles

Role of Allogeneic Stem Cell Transplantation (AlloSCT) in Patients Affected By Peripheral T-Cell Lymphomas (PTCL): No Difference in Outcome Between Patients Allografted at Diagnosis and in First Chemosensitive Relapse

Anna Dodero, MD, Francesco Spina, MD, Franco Narni, Francesca Patriarca, MD, Fabio Benedetti, MD, Donatella Baronciani, MD, Alessandro Rambaldi, Attilio Olivieri, MD, Serena Dalto, MD, Benedetto Bruno, MD, Umberto Vitolo, MD, Paolo Corradini, MD

Blood (2014) 124 (21): 2574.

https://doi.org/10.1182/blood.V124.21.2574.2574

Published: 2014

Journal Articles

Safety, Feasibility and Cost Of Hematopoietic Stem Cell Transplantation Management By Peripheral Inserted Central Catheter (PICC): A Phase II Prospective Study

Daniele Derudas, MD, Donatella Baronciani, MD, Cristina Depau, MD, Federica Pilo, MD, Clara Targhetta, MD, Sara Veronica Usai, MD, Giuseppe Longhitano, Daniela Ibba, Emanuele Angelucci

Blood (2013) 122 (21): 2971.

https://doi.org/10.1182/blood.V122.21.2971.2971

Published: 2013

Journal Articles

Hematopoietic Stem Cell Transplantation in Thalassemia Major. Report from the EBMT Hemoglobinopathy Registry

Donatella Baronciani, MD, Federica Pilo, MD, Sarah Lyon-Caen, MSc, Ulrike Poetschger, MSc, Giorgio Dini, MD, Christina Peters, MD

Blood (2011) 118 (21): 905.

https://doi.org/10.1182/blood.V118.21.905.905

Published: 2011

Journal Articles

Treosulfan - Fludarabine as Ablative Conditioning Regimen for Patients with High Risk Hematologic Malignancies.

Donatella Baronciani, MD, Alessandro Rambaldi, MD, Federica Pilo, MD, Caterina Mico, MD, Simona Deplano, MD, Cristina Depau, MD, Paolo Dessalvi, MD, Emanuele Angelucci, MD

Blood (2006) 108 (11): 5248.

https://doi.org/10.1182/blood.V108.11.5248.5248

Published: 2006

Journal Articles

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Martino Introna, MD, Gianmaria Borleri, Elena Conti, Anna M. Barbui, MD, Raewyn Broady, BSc, Erica Dander, BSc, Giuseppe Gaipa, BSc, Giovanna D’Amico, BSc, Ettore Biagi, MD, Matteo Parma, MD, Enrico Pogliani, MD, Orietta Spinelli, BSc, Donatella Baronciani, MD, Anna Grassi, MD, Josee Golay, PhD, Tiziano Barbui, MD, Andrea Biondi, MD, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 3698.

https://doi.org/10.1182/blood.V108.11.3698.3698

Published: 2006

Journal Articles

Hydroxyurea to Increase Hemoglobin Level in Thalassemia Intermedia.

Donatella Baronciani, MD, Stefania Vaquer, MD, Paola Carta, MD, Eliana Lai, MD

Blood (2004) 104 (11): 3769.

https://doi.org/10.1182/blood.V104.11.3769.3769

Published: 2004

NARROW

Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm

Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017

Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study

Once Daily Intravenous Busulphan Plus Fludarabine As New Reduced Toxicity Myeloablative Conditioning for Acute Myeloid Leukemia and MDS Allogeneic Transplantation

Role of Allogeneic Stem Cell Transplantation (AlloSCT) in Patients Affected By Peripheral T-Cell Lymphomas (PTCL): No Difference in Outcome Between Patients Allografted at Diagnosis and in First Chemosensitive Relapse

Safety, Feasibility and Cost Of Hematopoietic Stem Cell Transplantation Management By Peripheral Inserted Central Catheter (PICC): A Phase II Prospective Study

Hematopoietic Stem Cell Transplantation in Thalassemia Major. Report from the EBMT Hemoglobinopathy Registry

Treosulfan - Fludarabine as Ablative Conditioning Regimen for Patients with High Risk Hematologic Malignancies.

Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.

Hydroxyurea to Increase Hemoglobin Level in Thalassemia Intermedia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only